sulfamethizole has been researched along with Bright Disease in 1 studies
Sulfamethizole: A sulfathiazole antibacterial agent.
sulfamethizole : A sulfonamide consisting of a 1,3,4-thiadiazole nucleus with a methyl substituent at C-5 and a 4-aminobenzenesulfonamido group at C-2.
Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuller, J | 1 |
| First, MR | 1 |
| D'Achiardi, R | 1 |
| Munda, R | 1 |
1 other study available for sulfamethizole and Bright Disease
| Article | Year |
|---|---|
Pneumocystis carinii pneumonia in renal transplant recipients.
Topics: Adolescent; Adult; Drug Combinations; Female; Glomerulonephritis; Graft Rejection; Humans; Kidney Fa | 1982 |